You asked the case manager about complications.
She said no one at the clinic has ever hyperstimulated.
You trusted the answer less afterward.
Good instinct.
This piece uses one donor's hospital stay to show you how to read "low risk."
Low Risk Was the Pitch
A donor was told her cycle was low risk.
She ended up hospitalized with internal bleeding.
She nearly lost an ovary.
That outcome had not been part of the pitch.
Her story matters because of the job "low risk" was doing in that sentence.
It was closing a sale, and it wasn't reporting a measurement.
Here is how you can tell the difference.
A Reassurance Has No Count Behind It
You asked a direct question and got a direct-sounding answer.
One donor heard almost the same line, that hyperstimulation had never happened at that clinic.
Weeks later she lived it herself.
A spoken reassurance gives you no count, no timeframe, and no source.
Asking the same person harder questions won't fix that.
The fix is changing what you ask for.
Ask Who Counted the Two Percent
One agency's own material says serious OHSS is "less than 2%."
A researcher's donor data showed critical, hospitalization-level cases anyway.
Both can't be the whole picture.
So ask who calculated the figure.
Ask what counted as serious, and whether donors reported it or the clinic did.
If nobody can answer in writing, you're holding a slogan.
The Ad Left It Out
A study of recruitment ads found that 86.4% didn't mention OHSS.
83.5% didn't mention long-term risks at all.
If you've ever assumed they couldn't advertise something dangerous on a flyer, those numbers say otherwise.
The dollar figure got the headline.
In that study, 8 of 11 ads offering over $20,000 targeted women under 21.
Silence tells you what the ad was built to do.
No Known Long-Term Risk Means No One Looked
You already suspect this phrase is hollow.
You're right.
One donor learned, only after her own research, that her clinic's "no reported long-term harm" existed because no one ever looked.
Absence of a study isn't a finding.
Donors keep asking for a registry that tracks health outcomes across repeat cycles.
Until one exists, "no known risk" describes the gap in the research, and says nothing about your body.
A Smooth First Cycle Proves Little
Another donor was told her first bad cycle was "uncommon."
Her second retrieval produced 53 eggs and four days in intensive care.
If you're being called "proven," notice what that word pays for.
One donor's fee climbed from $6,000 to $10,000 and higher as she earned the label.
Six cycles is ASRM's own limit, because risk accumulates.
Pay keeps rising anyway, and a premium for proven fertility is a premium for accumulated risk.
Two Weeks Became Eight
Time commitments balloon past what recruitment implied.
Donors describe two weeks turning into eight or more.
Per diems run $50 to $75 a day, and travel eats into the total.
Then comes tax, which some donors discover only after signing.
One had to donate again just to cover the bill.
The $8,000 on the offer isn't the $8,000 in your account.
What the Contract Really Covers
Ask whether pay depends on cycle completion or on egg yield.
Ask what you're owed if the cycle is cancelled after medication starts.
Ask whether "covered" includes complications after the cycle, and for how long.
One donor was promised $10,000 within 90 days.
Five months later, she says, nothing had arrived.
Other donors found gaps in coverage and cancellation terms only after the fact.
Backing Out Has a Price Tag
One agency billed a donor $3,400 for screening and exam costs after she withdrew.
She had never started medication.
The dispute turned on whether medication had technically begun.
The agency dropped the bill only after she pushed back.
Other donors report reminders of how much the intended parents have already spent.
Withdrawal terms belong in writing before you sign.
The Guideline Was Never a Wall
The $10,000 figure gets called a law, a guideline, or agency policy.
It was a non-binding ASRM recommendation, later withdrawn after a legal challenge.
One agency says it caps pay at $10,000 and calls $100,000 offers "incredibly rare."
Other reporting suggests such sums circulate regularly.
One donor turned down $80,000 to $100,000 per cycle because the money seemed out of proportion to risks nobody had disclosed.
She was the only check in the room.
So How Do You Know What's True
If the guidance vanished and nobody enforces the cap, what can you believe?
Believe what has a name, a number, and a signature.
Whatever is only said to you, you can't check.
One forum poster said she "couldn't believe how in the dark" she was, even after informed consent paperwork.
Real disclosure reached her through other donors.
You've been doing that same work for weeks.
Ask Before You Sign
Send your questions by email, so the answers exist in writing.
What is my total pay, and what does it depend on?
What do I receive if the cycle is cancelled?
Who counted your OHSS rate, and how?
What does "covered" mean for complications after the cycle?
What do I owe if I withdraw before injections?
Vague answers tell you what you needed to know.
Specific ones are the first real information you've been given, so read them before anything else.